CYNERGISTEK INC/DE (CTEK) Stock Price & Overview
NYSEARCA:CTEK • US23258P1057
Current stock price
The current stock price of CTEK is 1.25 USD. Today CTEK is up by 1.63%. In the past month the price increased by 4.17%. In the past year, price decreased by -36.55%.
CTEK Key Statistics
- Market Cap
- 16.571M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.29
- Dividend Yield
- N/A
CTEK Stock Performance
CTEK Stock Chart
CTEK Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to CTEK. When comparing the yearly performance of all stocks, CTEK is a bad performer in the overall market: 69.77% of all stocks are doing better.
CTEK Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CTEK. CTEK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
CTEK Earnings
CTEK Forecast & Estimates
6 analysts have analysed CTEK and the average price target is 1.27 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 1.25.
For the next year, analysts expect an EPS growth of -23.1% and a revenue growth 16.51% for CTEK
CTEK Groups
Sector & Classification
CTEK Financial Highlights
Over the last trailing twelve months CTEK reported a non-GAAP Earnings per Share(EPS) of -0.29. The EPS decreased by -52.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -61.88% | ||
| ROA | -55.8% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
CTEK Ownership
CTEK Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 9.86 | 91.421B | ||
| CI | THE CIGNA GROUP | 8.41 | 69.722B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 98.65 | 28.394B | ||
| LH | LABCORP HOLDINGS INC | 14.4 | 21.761B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.18 | 21.332B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.685B | ||
| DVA | DAVITA INC | 10.56 | 10.004B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 29.72 | 8.514B | ||
| HIMS | HIMS & HERS HEALTH INC | 40.32 | 5.507B | ||
| CHE | CHEMED CORP | 15.59 | 5.299B | ||
| RDNT | RADNET INC | 77.29 | 4.848B | ||
| OPCH | OPTION CARE HEALTH INC | 14.76 | 4.557B | ||
| HNGE | HINGE HEALTH INC-A | 22.01 | 3.504B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CTEK
Company Profile
CynergisTek, Inc. engages in the provision of cybersecurity, privacy, and compliance services for companies. The company is headquartered in Austin, Texas and currently employs 89 full-time employees. The company went IPO on 2017-02-14. The firm is engaged in the business of providing companies with cybersecurity, privacy and compliance services through its assessment and technical testing, remediation, management, and validation services. The company serves companies in regulated industries, including healthcare, higher education, technology, government, manufacturing, and the financial sector through the CynergisTek, Backbone Consulting and Redspin brands. Its services are categorized into four service groups, which include Assess, Build, Manage, and Validate. The Assess service identifies, measures, and test security and privacy risk of an organization’s readiness and verify and validate programs through information technology audits, technical testing, and risk and program assessments. The Build service develops policies and procedures and playbooks to help build out a range of risk management programs.
Company Info
IPO: 2017-02-14
CYNERGISTEK INC/DE
11940 Jollyville Road, Suite 300-N
Austin TEXAS 78759 US
CEO: Caleb Barlow
Employees: 89
Phone: 19496140700.0
CYNERGISTEK INC/DE / CTEK FAQ
What does CYNERGISTEK INC/DE do?
CynergisTek, Inc. engages in the provision of cybersecurity, privacy, and compliance services for companies. The company is headquartered in Austin, Texas and currently employs 89 full-time employees. The company went IPO on 2017-02-14. The firm is engaged in the business of providing companies with cybersecurity, privacy and compliance services through its assessment and technical testing, remediation, management, and validation services. The company serves companies in regulated industries, including healthcare, higher education, technology, government, manufacturing, and the financial sector through the CynergisTek, Backbone Consulting and Redspin brands. Its services are categorized into four service groups, which include Assess, Build, Manage, and Validate. The Assess service identifies, measures, and test security and privacy risk of an organization’s readiness and verify and validate programs through information technology audits, technical testing, and risk and program assessments. The Build service develops policies and procedures and playbooks to help build out a range of risk management programs.
Can you provide the latest stock price for CYNERGISTEK INC/DE?
The current stock price of CTEK is 1.25 USD. The price increased by 1.63% in the last trading session.
Does CTEK stock pay dividends?
CTEK does not pay a dividend.
What is the ChartMill rating of CYNERGISTEK INC/DE stock?
CTEK has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Is CYNERGISTEK INC/DE (CTEK) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CTEK.
Is CYNERGISTEK INC/DE (CTEK) expected to grow?
The Revenue of CYNERGISTEK INC/DE (CTEK) is expected to grow by 16.51% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.